share_log

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A：並購重組委托聲明
美股SEC公告 ·  04/23 16:35

Moomoo AI 已提取核心訊息

SeaStar Medical Holding Corporation (SeaStar Medical) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on a date yet to be determined in April 2024. The meeting will address several key proposals, including the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Additionally, stockholders will vote on the approval of an amendment and restatement of the company's 2022 Omnibus Incentive Plan to increase the number of authorized shares. The meeting will also cover the approval of the issuance of 20% or more of the company's outstanding shares of common stock upon exercise of Series A and Series B Warrants, in compliance with Nasdaq Listing Rule 5635(d). Eric Schlorff, Director and CEO, has urged stockholders to vote promptly, highlighting the importance of their votes being represented. The meeting will be accessible online via www.proxydocs.com/ICU, where stockholders can enter their control number to attend and vote.
SeaStar Medical Holding Corporation (SeaStar Medical) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on a date yet to be determined in April 2024. The meeting will address several key proposals, including the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Additionally, stockholders will vote on the approval of an amendment and restatement of the company's 2022 Omnibus Incentive Plan to increase the number of authorized shares. The meeting will also cover the approval of the issuance of 20% or more of the company's outstanding shares of common stock upon exercise of Series A and Series B Warrants, in compliance with Nasdaq Listing Rule 5635(d). Eric Schlorff, Director and CEO, has urged stockholders to vote promptly, highlighting the importance of their votes being represented. The meeting will be accessible online via www.proxydocs.com/ICU, where stockholders can enter their control number to attend and vote.
海星醫療控股公司（SeaStar Medical）宣佈即將舉行的2024年年度股東大會，該會議計劃以虛擬方式舉行，日期尚未在2024年4月確定。會議將討論幾項關鍵提案，包括批准Withumsmith+Brown, PC 作爲截至2024年12月31日的財政年度的獨立註冊會計師事務所。此外，股東將投票批准公司2022年綜合激勵計劃的修正案和重述，以增加授權股票的數量。會議還將涵蓋根據納斯達克上市規則5635（d），批准在行使A系列和B系列認股權證時發行公司20％或以上的已發行普通股。董事兼首席執行官埃裏克·施洛夫（Eric Schlorff）敦促股東迅速投票，強調了代表他們的選票的重要性。該會議將通過www.proxydocs.com/ICU在線訪問，股東可以在其中輸入控制號碼參加和投票。
海星醫療控股公司（SeaStar Medical）宣佈即將舉行的2024年年度股東大會，該會議計劃以虛擬方式舉行，日期尚未在2024年4月確定。會議將討論幾項關鍵提案，包括批准Withumsmith+Brown, PC 作爲截至2024年12月31日的財政年度的獨立註冊會計師事務所。此外，股東將投票批准公司2022年綜合激勵計劃的修正案和重述，以增加授權股票的數量。會議還將涵蓋根據納斯達克上市規則5635（d），批准在行使A系列和B系列認股權證時發行公司20％或以上的已發行普通股。董事兼首席執行官埃裏克·施洛夫（Eric Schlorff）敦促股東迅速投票，強調了代表他們的選票的重要性。該會議將通過www.proxydocs.com/ICU在線訪問，股東可以在其中輸入控制號碼參加和投票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間